CRISPR partners with Sirius Therapeutics for siRNA therapies

1 month ago 2

Bill Oxford/iStock via Getty Images

• CRISPR Therapeutics (NASDAQ:CRSP) and Sirius Therapeutics have formed a partnership to jointly develop and commercialize small interfering RNA (siRNA) therapies.
• The collaboration will initially focus on co-developing SRSD107, a siRNA therapy targeting factor XI for the treatment of thromboembolic disorders.

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. CRISPR partners with Sirius Therapeutics for siRNA therapies